Bauman; John G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bauman; John G..The latest application filed is for "compounds and compositions for ocular delivery".

Company Profile

5.18.18

Bauman; John G. - El Sobrante CA
Bauman; John G. - El Sobrane CA
Bauman; John G - El Sobrante CA
Bauman; John G. - Alameda CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds And Compositions For Ocular Delivery App 20210214374 - Bauman; John G. ; et al.	2021-07-15
Drugs To Treat Ocular Disorders App 20210040111 - Yang; Ming ; et al.	2021-02-11
Drugs And Compositions For Ocular Delivery App 20200308162 - Cleland; Jeffrey L. ; et al.	2020-10-01
Drugs And Compositions For The Treatment Of Ocular Disorders App 20200031783 - Yang; Ming ; et al.	2020-01-30
Compounds and compositions for the treatment of ocular disorders Grant 10,485,876 - Cleland , et al. Nov	2019-11-26
Compounds And Compositions For The Treatment Of Ocular Disorders App 20190060474 - Cleland; Jeffrey L. ; et al.	2019-02-28
Compounds and compositions for the treatment of ocular disorders Grant 10,159,747 - Cleland , et al. Dec	2018-12-25
Compounds and compositions for the treatment of ocular disorders Grant 10,117,950 - Cleland , et al. November 6, 2	2018-11-06
Compounds and compositions for the treatment of ocular disorders Grant 10,111,964 - Cleland , et al. October 30, 2	2018-10-30
Compounds and compositions for the treatment of ocular disorders Grant 10,098,965 - Cleland , et al. October 16, 2	2018-10-16
Compounds and compositions for the treatment of ocular disorders Grant 9,956,302 - Cleland , et al. May 1, 2	2018-05-01
Compounds And Compositions For The Treatment Of Ocular Disorders App 20180110864 - Cleland; Jeffrey R. ; et al.	2018-04-26
Compounds And Compositions For The Treatment Of Ocular Disorders App 20180104350 - Cleland; Jeffrey L. ; et al.	2018-04-19
Compounds And Compositions For The Treatment Of Ocular Disorders App 20180064823 - Cleland; Jeffrey L. ; et al.	2018-03-08
Compounds And Compositions For The Treatment Of Ocular Disorders App 20180036416 - Cleland; Jeffrey L. ; et al.	2018-02-08
Compounds And Compositions For The Treatment Of Ocular Disorders App 20180028673 - Cleland; Jeffrey L. ; et al.	2018-02-01
Compounds and compositions for the treatment of ocular disorders Grant 9,808,531 - Cleland , et al. November 7, 2	2017-11-07
Compounds And Compositions for the Treatment of Ocular Disorders App 20170080092 - Cleland; Jeffrey L. ; et al.	2017-03-23
Intermediates for the preparation of lipoxin A.sub.4 analogs Grant 7,928,255 - Bauman , et al. April 19, 2	2011-04-19
Piperazine derivatives and their use as anti-inflammatory agents Grant 7,268,140 - Bauman , et al. September 11, 2	2007-09-11
Lipoxin A.sub.4 analogs Grant 7,223,798 - Bauman , et al. May 29, 2	2007-05-29
Intermediates for the preparation of lipoxin A4 analogs App 20070037864 - Bauman; John G. ; et al.	2007-02-15
Piperazine derivatives and their use as anti-inflammatory agents App 20060135487 - Bauman; John G. ; et al.	2006-06-22
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,977,258 - Bauman , et al. December 20, 2	2005-12-20
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,972,290 - Bauman , et al. December 6, 2	2005-12-06
Lipoxin A4 analogs Grant 6,831,186 - Bauman , et al. December 14, 2	2004-12-14
Lipoxin A4 analogs App 20040162433 - Bauman, John G. ; et al.	2004-08-19
Piperazine derivatives and their use as anti-inflammatory agents App 20030158205 - Bauman, John G. ; et al.	2003-08-21
Lipoxin A4 analogs App 20030139376 - Bauman, John G. ; et al.	2003-07-24
Piperazine derivatives and their use as anti-inflammatory agents App 20030139425 - Bauman, John G. ; et al.	2003-07-24
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,555,537 - Bauman , et al. April 29, 2	2003-04-29
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,541,476 - Bauman , et al. April 1, 2	2003-04-01
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,534,509 - Bauman , et al. March 18, 2	2003-03-18
Piperazine derivatives and their use as anti-inflammatory agents App 20020177598 - Bauman, John G. ; et al.	2002-11-28
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,207,665 - Bauman , et al. March 27, 2	2001-03-27
Process for the preparation of fludarabine or fludarabine phosphate from guanosine Grant 5,668,270 - Bauman , et al. September 16, 1	1997-09-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.